Are you energized by leadership education and the development of partnerships with key External Experts and Professional Bodies If so this Field Based Medical Science Liaison role could be an ideal opportunity to explore.As Field Based Medical Science Liaison (MSL) you will be respons

Are you energized by leadership education and the development of partnerships with key External Experts and Professional Bodies If so this Field Based Medical Science Liaison role could be an ideal opportunity to explore.As Field Based Medical Science Liaison (MSL) you will be respons

قدم الآن
دوام كامل

Position SummaryYou will lead and grow a quality control biochemistry team that ensures safe and compliant laboratory testing. You will work closely with production quality assurance and cross-functional partners. We value clear thinkers who coach others drive continuous improvement a

Position SummaryYou will lead and grow a quality control biochemistry team that ensures safe and compliant laboratory testing. You will work closely with production quality assurance and cross-functional partners. We value clear thinkers who coach others drive continuous improvement a

قدم الآن

The territory for this region includes Southern California Los Angeles Phoenix and Las Vegas.The Thought Leader Liaison (TLL) builds and manages strategic relationships with a select group of U.S. external experts within assigned therapeutic areasacross specialty groupsto generatetime

The territory for this region includes Southern California Los Angeles Phoenix and Las Vegas.The Thought Leader Liaison (TLL) builds and manages strategic relationships with a select group of U.S. external experts within assigned therapeutic areasacross specialty groupsto generatetime

قدم الآن
دوام كامل

At GSK we have bold ambitions for patients aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines combining our understanding of the immune system with cutting-edge technology to trans

At GSK we have bold ambitions for patients aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines combining our understanding of the immune system with cutting-edge technology to trans

قدم الآن

Business IntroductionAt GSK we have bold ambitions for patients aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines combining our understanding of the immune system with cutting-edg

Business IntroductionAt GSK we have bold ambitions for patients aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines combining our understanding of the immune system with cutting-edg

قدم الآن

Business IntroductionAt GSK we have bold ambitions for patients aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines combining our understanding of the immune system with cutting-edg

Business IntroductionAt GSK we have bold ambitions for patients aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines combining our understanding of the immune system with cutting-edg

قدم الآن

Business IntroductionAt GSK we have bold ambitions for patients aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines combining our understanding of the immune system with cutting-edg

Business IntroductionAt GSK we have bold ambitions for patients aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines combining our understanding of the immune system with cutting-edg

قدم الآن
دوام كامل

Welcome to Haleon. Were a purpose-driven world-class consumer company putting everyday health in the hands of just three years since our launch weve grown evolved and are now entering an exciting new chapter one filled with bold ambitions and enormous opportunity.Our trusted portfol

Welcome to Haleon. Were a purpose-driven world-class consumer company putting everyday health in the hands of just three years since our launch weve grown evolved and are now entering an exciting new chapter one filled with bold ambitions and enormous opportunity.Our trusted portfol

قدم الآن

The Director Global Content Design and Delivery Oncology in the Global Scientific Communications organization is responsible for chairing Global Integrated Medical Communication Teams (GIMCT) for a Oncology asset/disease area and driving the development of Integrated Medical Communica

The Director Global Content Design and Delivery Oncology in the Global Scientific Communications organization is responsible for chairing Global Integrated Medical Communication Teams (GIMCT) for a Oncology asset/disease area and driving the development of Integrated Medical Communica

قدم الآن
دوام كامل

Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient

Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient

قدم الآن
دوام كامل

Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient

Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient

قدم الآن
دوام كامل

Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient

Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient

قدم الآن
دوام كامل

Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient

Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient

قدم الآن
دوام كامل

Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient

Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient

قدم الآن

Job title: Medical Manager Specialty PipelineLocation: Greece FieldbasedPosition SummaryYou will be a Medical Manager Specialty Pipeline based in Greece with a strong focus on clinical development activities. You will act as the local medical interface for investigators clinical site

Job title: Medical Manager Specialty PipelineLocation: Greece FieldbasedPosition SummaryYou will be a Medical Manager Specialty Pipeline based in Greece with a strong focus on clinical development activities. You will act as the local medical interface for investigators clinical site

قدم الآن
دوام كامل

Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient

Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient

قدم الآن

Position SummaryYou will manage the Manufacturing Science and Technology (MSAT) Drug Product technical delivery for drug product manufacturing of a defined product or product family with a primary focus on New Product Introduction (NPI) and successful product launches including delive

Position SummaryYou will manage the Manufacturing Science and Technology (MSAT) Drug Product technical delivery for drug product manufacturing of a defined product or product family with a primary focus on New Product Introduction (NPI) and successful product launches including delive

قدم الآن

Job DescriptionBusiness Introduction:GSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of bil

Job DescriptionBusiness Introduction:GSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of bil

قدم الآن

Are you energized by leadership education and the development of partnerships with key External Experts and Professional Bodies If so this Field Based Medical Science Liaison role could be an ideal opportunity to explore.As Field Based Medical Science Liaison (MSL) you will be respons

Are you energized by leadership education and the development of partnerships with key External Experts and Professional Bodies If so this Field Based Medical Science Liaison role could be an ideal opportunity to explore.As Field Based Medical Science Liaison (MSL) you will be respons

قدم الآن

The territory for this region includes Illinois Indiana Michigan Kentucky Tennessee and Ohio.The Thought Leader Liaison (TLL) builds and manages strategic relationships with a select group of U.S. external experts within assigned therapeutic areasacross specialty groupsto generatetime

The territory for this region includes Illinois Indiana Michigan Kentucky Tennessee and Ohio.The Thought Leader Liaison (TLL) builds and manages strategic relationships with a select group of U.S. external experts within assigned therapeutic areasacross specialty groupsto generatetime

قدم الآن